Search by Drug Name or NDC
NDC 63323-0099-63 Sodium Chloride 4 meq/mL Details
Sodium Chloride 4 meq/mL
Sodium Chloride is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is SODIUM CHLORIDE.
Product Information
| NDC | 63323-0099 |
|---|---|
| Product ID | 63323-099_f5197532-af45-42c9-919b-30d00276650e |
| Associated GPIs | |
| GCN Sequence Number | 001220 |
| GCN Sequence Number Description | sodium chloride VIAL 4 MEQ/ML INTRAVEN |
| HIC3 | C1B |
| HIC3 Description | SODIUM/SALINE PREPARATIONS |
| GCN | 02971 |
| HICL Sequence Number | 000538 |
| HICL Sequence Number Description | SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | meq/mL |
| Substance Name | SODIUM CHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217796 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0099-63 (63323009963)
| NDC Package Code | 63323-099-63 |
|---|---|
| Billing NDC | 63323009963 |
| Package | 10 VIAL, PLASTIC in 1 TRAY (63323-099-63) / 200 mL in 1 VIAL, PLASTIC (63323-099-03) |
| Marketing Start Date | 2023-07-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |